- Report
- October 2024
- 70 Pages
China
From €848EUR$950USD£742GBP
- Report
- October 2024
- 70 Pages
France
From €848EUR$950USD£742GBP
- Report
- October 2024
- 70 Pages
Germany
From €848EUR$950USD£742GBP
- Report
- October 2024
- 70 Pages
India
From €848EUR$950USD£742GBP
- Report
- October 2024
- 70 Pages
United States
From €848EUR$950USD£742GBP
- Report
- September 2024
- 103 Pages
United States
From €2227EUR$2,495USD£1,949GBP
- Report
- September 2024
- 97 Pages
Global
From €4329EUR$4,850USD£3,788GBP
- Report
- July 2024
- 639 Pages
Global
From €3794EUR$4,250USD£3,319GBP
- Report
- July 2024
- 187 Pages
China
From €1607EUR$1,800USD£1,406GBP
- Report
- July 2024
- 243 Pages
China
From €3570EUR$4,000USD£3,124GBP
- Report
- July 2024
- 90 Pages
China
From €1607EUR$1,800USD£1,406GBP
- Report
- July 2024
- 326 Pages
China
From €3570EUR$4,000USD£3,124GBP
- Report
- June 2024
- 211 Pages
Global
From €3794EUR$4,250USD£3,319GBP
- Report
- March 2024
- 118 Pages
Global
From €4017EUR$4,500USD£3,515GBP
- Report
- March 2024
- 200 Pages
Global
From €3704EUR$4,150USD£3,241GBP
- Report
- February 2024
- 116 Pages
Global
From €4454EUR$4,990USD£3,897GBP
- Training
- February 2024
- 90 Minutes
Global
From €620EUR$695USD£543GBP
- Report
- February 2024
- 16 Pages
Global
- Report
- January 2024
- 310 Pages
Global
From €2499EUR$2,800USD£2,187GBP
€3124EUR$3,500USD£2,734GBP
- Report
- January 2024
- 250 Pages
Global
€4458EUR$4,995USD£3,901GBP

The biopharmaceuticals market is a sector of the pharmaceutical industry that focuses on the development and production of drugs derived from biological sources. These drugs are typically produced using recombinant DNA technology, which involves the manipulation of genetic material to create proteins and other molecules with therapeutic properties. Biopharmaceuticals are used to treat a wide range of diseases, including cancer, HIV/AIDS, and autoimmune disorders.
Biopharmaceuticals are typically more expensive to produce than traditional pharmaceuticals, but they offer a number of advantages, such as improved efficacy and fewer side effects. They are also more targeted, meaning they can be used to treat specific conditions more effectively.
Some of the major companies in the biopharmaceuticals market include Amgen, Biogen, Celgene, Gilead Sciences, and Novartis. These companies are involved in the development and production of a wide range of biopharmaceuticals, including monoclonal antibodies, vaccines, and gene therapies. Show Less Read more